Aegean Conferences is an independent, nonprofit, educational organization directed and managed by the scientific community. The board is made up of nine researchers/scientists in various disciplines from Harvard, Brown, University of Pennsylvania, UCSD, Princeton, Biovista and the Foundation for Biomedical Research Academy of Athens. The board both invites and approves unsolicited proposals for Conferences in all fields of Science, Engineering, Arts, and Humanities. The purpose of the Conferences is to bring together individuals with common interests to examine the emerging and most advanced aspects of their particular field.

The Symposium on Ovarian Cancer: State of the Art and Future Directions intends to bring together international experts interested in the development of novel diagnostic, prognostic and therapeutic tools for ovarian cancer. The meeting will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances in clinical research and translational science in ovarian cancer and define areas of future research opportunities and priorities.

Completely reorganized to be more clinically focused on diagnosis and treatment, Principles and Practice of Gynecologic Oncology, Eighth Edition, provides the up-to-date information practitioners, researchers, and students need in an easily accessible manner. Drs. Dennis S. Chi, Dineo Khabele, Don S. Dizon, and Catheryn Yashar oversee an expert team of international, multidisciplinary authors who offer practical coverage of the entire field, including new management and treatment strategies for gynecologic cancers. Each disease site now has a dedicated section with individual chapters on epidemiology, pathogenesis, prevention, diagnostic imaging, radiation, chemotherapy, targeted therapy, and more—all designed for  quick clinical reference and efficient study.  Features a multidisciplinary approach to treatment and care including expert views from radiation oncology, pathology, internal medicine, gastroenterology and nutrition, neurology, pharmacy, genetics, and epidemiology, in addition to medical oncology and surgery  Provides international perspectives in every chapter, offering unique perspectives on incidence, mortality, and treatment worldwide, as well as commentary on similarities and differences in management  Covers special topics such as perioperative and critical care; surgical procedures; cost-effective and value-based cancer care; pain, nutrition, and palliative care; and a new chapter on supportive care  Includes access to more than two dozen videos  Highlights authoritative content with hundreds of high-quality, full-color illustrations and nearly 250 tables for quick reference    Enrich Your eBook Reading Experience  Read directly on your preferred device(s), such as computer, tablet, or smartphone.  Easily convert to audiobook, powering your content with natural language text-to-speech. 

This authoritative reference compiles the latest studies on the epidemiology, diagnosis, and treatment of uterine cancer and offers an extensive review of the molecular pathogenesis of endometrial and uterine disorders-analyzing patterns of disease presentation as population demographics change and considering the challenges this will place on future healthcare procedures.

Aegean Conferences is an independent, nonprofit, educational organization directed and managed by the scientific community. The board is made up of nine researchers/scientists in various disciplines from Harvard, Brown, University of Pennsylvania, UCSD, Princeton, Biovista and the Foundation for Biomedical Research Academy of Athens. The board both invites and approves unsolicited proposals for Conferences in all fields of Science, Engineering, Arts, and Humanities. The purpose of the Conferences is to bring together individuals with common interests to examine the emerging and most advanced aspects of their particular field.

The Symposium on Ovarian Cancer: State of the Art and Future Directions intends to bring together international experts interested in the development of novel diagnostic, prognostic and therapeutic tools for ovarian cancer. The meeting will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances in clinical research and translational science in ovarian cancer and define areas of future research opportunities and priorities.